Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck and Ariad say FDA will review application for their sarcoma pill ridaforolimus
Merck and Ariad say FDA will review application for their sarcoma pill ridaforolimus
Merck and Ariad say FDA will review application for their sarcoma pill ridaforolimus
Submitted by
admin
on October 5, 2011 - 10:52am
Source:
Yahoo/AP
News Tags:
FDA
sarcoma
ridaforolimus
Merck
Ariad Pharmaceuticals
Headline:
Merck and Ariad say FDA will review application for their sarcoma pill ridaforolimus
Do Not Allow Advertisers to Use My Personal information
